The Biopreservation Market 2018: Market Size, Share & Trends Analysis by Product, Application and Cell Provider (2012-2022) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 7, 2018--The “Biopreservation Market Size, Share & Trends Analysis Report By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine, Bio-banking, Drug Discovery), By Cell Provider, And Segment Forecasts, 2012 - 2022” report has been added to ResearchAndMarkets.com’s offering.The global biopreservation market size is expected to reach USD 8.93 billion by 2022, exhibiting a 17.3% CAGR during the forecast period.Rising demand for advanced preservation methods and constantly increasing healthcare spending is anticipated to fuel growth potential in future.Hospitals, pharmaceutical companies, and biotechnology firms are increasingly adopting systems for in-house storage of samples and this is anticipated to provide a significant boost to the market.Surging R&D investments by major companies and research communities striving to improve product development capabilities is also presenting the market with immense potential.Technological advancements such as advent of virtual bio-banks, which is predicted to witness a significant upsurge in the application, is also resulting in market progression.In addition, increasing preference for maintaining repositories for biological specimens, for application in organ transplantation and regenerative medicine, has benefited the market.Presence of government initiatives such as International Society of Biological and Environmental Repositories to enhance bio-banking and preservation standards and practices is also broadening the scope for growth over the coming years.
Key FindingsIn 2014, equipment captured the dominant share by product owing to growing demand from bio-banks. High preservation costs of biological specimens has also benefited this segment.The media segment, on the other hand, is predicted to witness exponential CAGR during the coming years as a result of wide adoption in regenerative medicine.In 2014, bio-banking captured a substantial share in terms of application owing to growing number of tissue and organ transplantations and high awareness levels with respect to bio-banking.Regenerative medicine, on the other hand, is anticipated to register the highest CAGR owing to major investments by public and private healthcare organizations in research focused on restorative therapy.By cell provider, tumor cells captured the largest share in terms of volume in 2014, as a consequence of extensive application in R&D and treatment of cancers with high prevalence.
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Bio-preservation Industry Outlook
Chapter 4. Bio-preservation Product Outlook
Chapter 5. Bio-Preservation Application Outlook
Chapter 6. Bio-Preservation Cell Providers Outlook
Chapter 7. Bio-preservation Regional Outlook
Chapter 8. Competitive LandscapeBioCision, LLCBiomatrica, Inc.BioLife Solutions, Inc.Chart MVE BiomedicalLabVantage Solutions, Inc.Atlanta Biologics Inc.Taylor-Wharton Cryogenics LLCPanasonic CorporationThermo Fisher Scientific, Inc.Qiagen N.V.VWR International, LLCBIOGENICS
For more information about this report visit https://www.researchandmarkets.com/research/74xchg/the?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005477/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/07/2018 07:44 AM/DISC: 11/07/2018 09:33 AM